Search
Janux Therapeutics Inc
JANXAdd to Watchlist
15.540USD
+0.880+6.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
945.85MMarket Cap
LossP/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-01The current institutional shareholding score of Janux Therapeutics Inc is 10.00, ranking 1 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 110.21%, representing a quarter-over-quarter increase of 0.64%. The largest institutional shareholder is Steven Cohen, holding a total of 1.11M shares, representing 1.90% of shares outstanding, with 62.25% decrease in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
RA Capital Management, LP
Janus Henderson Investors
BlackRock Institutional Trust Company, N.A.
Prosight Capital
Bregua Corp
State Street Investment Management (US)
Fidelity Management & Research Company LLC
OrbiMed Advisors, LLC
1
2